Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Naproxcinod

EU orphan designation number: EU/3/13/1194
Active ingredient: Naproxcinod
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: NicOx
Drakkar 2- Bat D, 2405 route des Dolines, CS 10313 Sophia Antipolis, 06560 Valbonne, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/10/2013 Orphan designation EMA/OD/090/13 (2013)6739 of 07/10/2013
19/12/2017 Removal of orphan designation from Community Register